quinuclidines has been researched along with Infarction, Middle Cerebral Artery in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, S; Jiang, T; Ma, Z; Pu, K; Wang, Q; Wu, M; Yan, C; Yuan, W; Zhang, Z | 1 |
| Akino, H; Aoki, Y; Ito, H; Nagase, K; Tanase, K; Yokoyama, O | 1 |
| Chen, S; Gou, X; Huang, Y; Li, X; Wang, F; Wang, Q; Xiong, L; Xu, N; Yang, Q; Zhang, Q | 1 |
| Hayashi, A; Noguchi, Y; Ohtake, A; Okutsu, H; Sasamata, M; Sato, S; Suzuki, M; Ukai, M; Yoshino, T; Yuyama, H | 1 |
4 other study(ies) available for quinuclidines and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Electroacupuncture attenuated cerebral ischemic injury and neuroinflammation through α7nAChR-mediated inhibition of NLRP3 inflammasome in stroke rats.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Blotting, Western; Brain Ischemia; Bridged Bicyclo Compounds, Heterocyclic; Electroacupuncture; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Inflammasomes; Inflammation; Injections, Intraventricular; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Quinuclidines; Rats; Rats, Sprague-Dawley; Signal Transduction | 2019 |
Co-administration of an α(1) -blocker improves the efficacy and safety of antimuscarinic agents in rats with detrusor overactivity.
Topics: Adrenergic alpha-1 Receptor Antagonists; Analysis of Variance; Animals; Disease Models, Animal; Diterpenes; Drug Therapy, Combination; Female; Infarction, Middle Cerebral Artery; Muscarinic Antagonists; Muscle Contraction; Organ Size; Quinuclidines; Rats; Rats, Sprague-Dawley; Solifenacin Succinate; Statistics, Nonparametric; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urinary Bladder, Overactive | 2011 |
Electroacupuncture pretreatment attenuates cerebral ischemic injury through α7 nicotinic acetylcholine receptor-mediated inhibition of high-mobility group box 1 release in rats.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Brain Injuries; Bridged Bicyclo Compounds, Heterocyclic; Bungarotoxins; Cells, Cultured; Cerebral Cortex; Cerebral Infarction; Disease Models, Animal; Electroacupuncture; Embryo, Mammalian; Gene Expression Regulation; Glucose; HMGB1 Protein; Hypoxia; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Injections, Intraventricular; L-Lactate Dehydrogenase; Male; Neurons; Neuroprotective Agents; Phosphopyruvate Hydratase; Protein Binding; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Statistics, Nonparametric; Tetrazolium Salts; Thiazoles | 2012 |
Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats.
Topics: Animals; Benzhydryl Compounds; Benzilates; Cresols; Infarction, Middle Cerebral Artery; Male; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Quinuclidines; Rats; Rats, Sprague-Dawley; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Neurogenic | 2005 |